Fred Hutchinson
‘On-your-toes’ approach to managing infection risk needed as CAR T-cell therapy evolves
Chimeric antigen receptor T-cell therapy employs a patient’s immune system to fight cancer and thereby weakens it, leaving the recipient vulnerable to infection.
Ruxolitinib improves response rate, failure-free survival in chronic GVHD
Ruxolitinib appeared more effective than best available therapy for steroid-refractory or steroid-dependent chronic graft-versus-host disease, according to randomized phase 3 study results presented at TCT Meetings Digital Experience.
Oncologists can allay COVID-19 vaccination concerns of patients with cancer, survivors
Oncologists are in a critical position to provide potentially life-saving information about the COVID-19 vaccine to their patients with cancer, experts said.
Declines in prostate cancer screening after 2012 USPSTF guidance vary by race, ethnicity
Prostate cancer screening rates appeared to differ among Black, white, Hispanic and Asian/Pacific Islander men following the 2012 U.S. Preventive Services Task Force recommendation against routine PSA testing, according to study results.
Sitagliptin may prevent acute GVHD after peripheral blood stem cell transplantation
Sitagliptin significantly reduced incidence of acute graft-versus-host disease after myeloablative allogeneic peripheral blood stem cell transplantation, according to phase 2 study results published in The New England Journal of Medicine.
Fauci: COVID-19 can be crushed, ‘but it’s not going to happen in a few months’
Despite promising data that have emerged on COVID-19 vaccine candidates, a return to normal “carefree” life is likely years out, according to Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.
Finding Your Own Way with Julie Gralow, MD
Julie Gralow, MD, is a well-respected and internationally renowned breast oncologist. In this episode, Gralow discusses her journey in oncology, the ASCO Global Oncology Task Force and the importance of finding your own way in medicine.
ASH announces four new executive committee members
ASH announced the election of four new members to its executive committee.
Global Oncology with Ben Anderson, MD
In this episode, Benjamin O. Anderson, MD, FACS, creator and chair of The Breast Health Global Initiative at Fred Hutchinson Cancer Research Center, shares how his passion for patient care dovetailed into a career in global oncology.
Post-infusion CAR-T costs considerably higher at academic inpatient hospitals
Chimeric antigen receptor T-cell therapy administration cost nearly $33,000 more at academic inpatient hospitals than nonacademic specialty oncology networks, according to study results published in JAMA Network Open.